Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Diabetic Ketoacidosis
Related studies linked through entity extraction aliases.
Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes
- Status
- TERMINATED
- Phase
- NA
Diabetic Ketoacidosis: Brain Morphology and Cognition
- Status
- COMPLETED
- Phase
- N/A
DKA Optic Ultrasound
- Status
- UNKNOWN
- Phase
- N/A
Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis
- Status
- COMPLETED
- Phase
- NA
Evaluation of a Non-invasive Brain Compliance Measurement Device
- Status
- COMPLETED
- Phase
- N/A
Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis
- Status
- COMPLETED
- Phase
- PHASE3
Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA
- Status
- COMPLETED
- Phase
- NA
Cerebral Edema in Pediatric Diabetic Ketoacidosis
- Status
- COMPLETED
- Phase
- NA
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
- Status
- COMPLETED
- Phase
- PHASE4
Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
- Status
- COMPLETED
- Phase
- N/A
Ketosis Prone Diabetes in African-Americans
- Status
- COMPLETED
- Phase
- N/A
Use of Insulin Glargine to Treat Diabetic Ketoacidosis
- Status
- COMPLETED
- Phase
- NA